# A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis

> **NCT07374471** · PHASE1,PHASE2 · RECRUITING · sponsor: **Mage Biologics** · enrollment: 100 (estimated)

## Conditions studied

- Ulcerative Colitis (UC)

## Interventions

- **BIOLOGICAL:** MB-001
- **BIOLOGICAL:** Matching placebo to MB-001

## Key facts

- **NCT ID:** NCT07374471
- **Lead sponsor:** Mage Biologics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2028-07
- **Final completion:** 2028-08
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07374471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07374471, "A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07374471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*